Aldioxa
| Code | Size | Price |
|---|
| TAR-T29850-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Aldioxa is a Gastrointestinal Agent.
CAS:
5579-81-7
Formula:
C4H7AlN4O5
Molecular Weight:
218.105
Purity:
0.98
SMILES:
NC(=O)N[C@@H]1N=C(NC1=O)O[Al](O)O
References
1. Asano T, Aida S, Suemasu S, Tahara K, Tanaka K, Mizushima T. Aldioxa improves delayed gastric emptying and impaired gastric compliance, pathophysiologic mechanisms of functional dyspepsia. Sci Rep. 2015 Dec 1;5:17519. doi: 10.1038/srep17519. PubMed PMID: 26620883; PubMed Central PMCID: PMC4664916.
2. Llena C, Forner L, Vento C. Anticalculus efficacy of a new dentifrice. Quintessence Int. 2009 Jun;40(6):497-501. PubMed PMID: 19587891.
3. Guillard O, Huguet F, Fauconneau B, Piriou A, Pineau A. Absence of gastrointestinal absorption or urinary excretion of aluminium from an allantoinate complex contained in two antacid formulations in patients with normal renal function. Eur J Clin Chem Clin Biochem. 1996 Aug;34(8):609-12. PubMed PMID: 8877335.
4. Uchida M, Hamura H, Takagi S, Noguchi Y, Shibata H, Honda H. [Acidified aspirin-induced gastric lesion in rats with hepatic cirrhosis produced by N-nitrosodiethylamine or carbon tetrachloride. Effect of aldioxa on gastric lesions]. Nihon Yakurigaku Zasshi. 1994 Mar;103(3):111-20. Japanese. PubMed PMID: 8144103.